Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.2 USD | -13.73% | -3.08% | +18.92% |
Business Summary
Number of employees: 27
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lisa Ricciardi
CEO | Chief Executive Officer | 64 | 19-02-28 |
John Doyle
DFI | Director of Finance/CFO | 46 | 23-04-30 |
Paul J. Tiseo
CTO | Chief Tech/Sci/R&D Officer | - | 22-10-10 |
Mary Hamby
CTO | Chief Tech/Sci/R&D Officer | - | - |
Anthony Caggiano
CTO | Chief Tech/Sci/R&D Officer | 54 | 19-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Ricciardi
CEO | Chief Executive Officer | 64 | 19-02-28 |
Brett Monia
BRD | Director/Board Member | 62 | 20-09-30 |
Ellen Richstone
BRD | Director/Board Member | 72 | 21-10-31 |
Jack Khattar
CHM | Chairman | 62 | 19-12-31 |
Peggy Wallace
BRD | Director/Board Member | 67 | 16-08-31 |
Aaron Fletcher
BRD | Director/Board Member | 44 | 14-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 40,058,498 | 38,448,014 ( 95.98 %) | 0 | 95.98 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.92% | 88.13M | |
+9.83% | 115B | |
+10.80% | 105B | |
-10.84% | 22.71B | |
-1.22% | 21.83B | |
-11.18% | 18.18B | |
-41.92% | 16.52B | |
-15.11% | 16.01B | |
+6.62% | 14.14B | |
+17.53% | 10.71B |
- Stock Market
- Equities
- CGTX Stock
- Company Cognition Therapeutics, Inc.